Platelet Rich Plasma Tubes Market Size & Growth | Report 2028

The global platelet rich plasma (PRP) tubes market is expected to reach US$ 1,640.94 million by 2028 from US$ 565.10 million in 2021. The market is estimated to record a CAGR of 16.5% from 2022 to 2028.

Platelet-rich plasma (PRP) tubes are vacuum sealed tubes that hold blood sample for platelet recovery. The tubes can also hold gel, buffy coat layer, or sodium citrate solution, which helps separate PRP and prevents blood clotting. PRP tubes are used to isolate platelets and eliminate unwanted components such as red blood cells and inflammatory white blood cells. The substances in the PRP tubes enable the production of autologous plasma, which has a therapeutic effect and is suitable for injection into the body. The rising number of cosmetic and aesthetic procedures and the increasing cases of sports injuries drive the platelet rich plasma (PRP) tubes market growth. However, the high cost and adverse effects of PRP treatment are hindering the market growth.

The platelet rich plasma (PRP) tubes market has been segmented on the basis of usage, volume, end user, and geography. In terms of geography, the market is primarily segmented into North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America. The report offers insights and in-depth analysis of the market, emphasizing parameters such as platelet rich plasma (PRP) tubes market trends, technological advancements, market dynamics, and the competitive landscape analysis of leading market players.

Strategic Insights

Lucrative Regions for Platelet Rich Plasma (PRP) Tubes Market

Get more information on this report : Request Free Sample PDF

Market Insights

Rising Number of Cosmetic and Aesthetic Procedures Accelerate Market Growth

PRP procedures utilize the body’s natural tissue repair process to achieve improved form and function. The procedure is intended for several noninvasive cosmetic skin treatments. It shows promising results in plastic surgery. In aesthetic procedures, PRP is used to improve skin texture; add volume to the face, hands, and neck; treat fine lines and wrinkles around the eyes; minimize wrinkles and lines around the mouth; and treat acne scars and stretch marks. Characteristics of PRP such as ease of use, inexpensive to produce utilizing patient’s cells, and little or no risk of adverse reactions propel the adoption of PRP in treatments. The American Society of Plastic Surgeons (ASPS) produced a report on the use of PRP. According to a survey of the International Society of Aesthetic Plastic Surgery (ISAPS), ~10.1 million surgical procedures, including eyelid surgery, ear surgery, and Liposuction, and 14.4 million nonsurgical procedures such as hair removal, photo rejuvenation, and botulinum toxin were performed across the world in 2020. The number of nonsurgical and surgical cosmetic procedures increased significantly in the US, by over 1.56 million in 2021. Nonsurgical procedures have considerably outrun surgical procedures. In 2021, over 5.5 million procedures involved toxins and fillers in the US.

The medical aesthetics industry in the UAE is growing due to an increasing number of local and international patients opting for plastic surgery, cosmetics, growing medical tourism, and a rising number of internationally trained industry professionals in the country. In addition, Dubai is a medical tourism hotspot in the Middle East, accounting for 1.3 million medical tourists in 2021, as per the Wisconsin Economic Development Corporation 2022 report. In 2016, the Dubai Health Authority (DHA) announced its plan to launch the Dubai Health Experience Program. The program is the world's first comprehensive electronic medical tourism portal that offers medical packages comprising health, travel, hospitality, and visa services. The medical packages also cover wellness, cosmetic, orthopedic procedures, and specialized medical tests. The growing medical tourism and increasing medical packages support the growth of cosmetic and aesthetic procedures. As a result, the demand for PRP tubes is growing, which is driving the platelet rich plasma (PRP) tubes market growth.

Platelet Rich Plasma (PRP) Tubes Market, by Usage – 2022 Vs. 2028

Get more information on this report : Request Free Sample PDF

Based on usage, the platelet rich plasma (PRP) tubes market is segmented into skin rejuvenation, hair restoration, orthopedics, surgical oncology, gynaecology, and others. The orthopedics segment held the largest market share in 2021. However, the skin rejuvenation segment is anticipated to register the highest CAGR in the market during the forecast period.

Volume-Based Insights

In terms of volume, the platelet rich plasma (PRP) tubes market is segmented into less than 5ml, 6ml to 10ml, and more than 10ml. The more than 10ml segment held the largest share of the market in 2021 and is anticipated to register the highest CAGR of the market during the forecast period.

End User-Based Insights

By end user, the platelet rich plasma (PRP) tubes market is segmented into medspa, dermatology office, hospitals & healthcare practices, tricologist, and others. The hospitals and healthcare practices segment held the largest share of the market in 2021 and is anticipated to register the highest CAGR in the market during the forecast period.

During COVID-19 pandemic, the demand for aesthetic procedures was reduced as the healthcare sector in North America focused on COVID-19 patients. The pandemic led to massive disruptions in global supply chains, consumer markets, and economies. As a result of the measures implemented by governments, there was a risk of a temporary and significant decline in demand for aesthetic procedures in the region.  Various companies reported severe losses in the last quarter of 2019 and negative impacts on the businesses in 2020. Countries imposed complete lockdowns to control the spread of virus infection. During lockdowns, economic growth was declined due to closed trades and businesses.  Moreover, according to a report by French Cosmetic Association for SMEs (COSMED) in October 2020, COVID-19 pandemic hit French cosmetics firms, with very few experiencing opportunities. COSMED reported that the pandemic had negatively impacted around 80% of the turnover of small and medium cosmetic companies. Thus, the pandemic impact is causing stagnation in consumer purchases and business economic activities.

Companies in the platelet rich plasma (PRP) tubes market commonly adopt product launches and expansion strategies to expand their footprint across the world and meet the growing demand. Their focus on product innovation allows them to cater to changing customer demands and maintain their brand name across the globe.

• In September 2022, Suneva Medical, Inc., a leader in regenerative aesthetics,  launched the 30 ml iteration of their Amplifine Platelet Rich Plasma (PRP) gel tubes, which will help medical practitioners with a larger volume of PRP and help in addressing several areas of concern efficiently.
• In November 2020, Crown Aesthetics, a division of Crown Laboratories, Inc. (a global skincare company), completed the rebranding of ProGen PRP Advantage, renamed as ProGen PRP Eclipse.  ProGen PRP Eclipse, the gold standard in PRP, is an easy-to-use, one-spin system that features 15 ml and 30 ml tubes, yielding 7–15 ml of PRP. The company is focused on developing and offering a diverse portfolio of aesthetic, premium, and therapeutic skincare products that improve the quality of life for its consumers throughout their skincare journey.

In terms of geography, the global platelet rich plasma (PRP) tubes market is segmented into North America (the US, Canada, and Mexico), Europe (France, Germany, the UK, Spain, Italy, and the Rest of Europe), Asia Pacific (China, India, Japan, Australia, South Korea, and the Rest of APAC), the Middle East & Africa (Saudi Arabia, the UAE, South Africa, and the Rest of MEA), and South & Central America (Brazil, Argentina, and the Rest of South & Central America).

Platelet Rich Plasma (PRP) Tubes Market - Company Profiles

• Manso Medical Co Ltd
• Lingen Precision Medical Products Co Ltd
• Integrity PRP
• Henso Medical (Hangzhou) Co Ltd
• Emerging Medical Group LLC
• Juventix Regenerative Medical LLC
• AdvaCare Pharma USA LLC
• Advin Health Care
• Promed Solutions
• BIO-X